<DOC>
	<DOCNO>NCT00824070</DOCNO>
	<brief_summary>This study conduct assess concentration besifloxacin , moxifloxacin , gatifloxacin aqueous humor sample collect follow topical instillation associate formulation subject undergoing cataract surgery .</brief_summary>
	<brief_title>Assessment Concentrations Besifloxacin , Moxifloxacin , Gatifloxacin Aqueous Humor Subjects</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>7- ( 3-aminohexahydro-1H-azepin-1-yl ) -8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Subjects candidate routine , uncomplicated , primary cataract extraction . Subjects , Investigator 's opinion , potential postoperative best correct Snellen visual acuity least 20/200 study eye . Subjects know sensitivity , contraindication , allergy study medication ( ) component . Subjects corneal refractive surgery study eye . Subjects history presence chronic generalize systemic disease Investigator feel might increase risk subject confound result study . Subjects ocular surgery study eye , include laser procedure , within past 6 month . Subjects take topical ocular medication study eye , require protocol permit surgery , 24 hour prior study medication instill . Subjects use antibiotic ( e.g. , systemic topical ) within 7 day prior surgery date . Subjects monocular .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Bioavailability</keyword>
</DOC>